Recent research focusing on Retatrutide at a dosage of 30mg is shedding new light on its potential benefits. Preliminary findings suggest that this higher dosage may boost the drug's ability to control blood levels, potentially offering improved outcomes for individuals with insulin resistance. Further investigation is underway to fully explore the